🇺🇸 FDA

Intelligence · Patent portfolio

RIGEL PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for RIGEL PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
373
Expiring ≤24m
18

Quick answer

RIGEL PHARMACEUTICALS has 373 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 18 expire within 24 months — use filters for patent-cliff planning.

Page 7 of 8

  1. US 7872000

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7872096

    Methods for cyclizing synthetic polymers

    Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7868013

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7863286

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7858633

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7851480

    Spiro 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7834024

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7825116

    N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7820819

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7812029

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7803939

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7776847

    Benzisothiazoles useful for treating or preventing HCV infection

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7754714

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7723018

    Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7713987

    Pyrimidine-2,4-diamines and their uses

    Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7714137

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7709482

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7659280

    2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7655797

    Intermediates for making 2,4-pyrimidinediamine compounds

    Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7601713

    Kinase inhibitors and their uses

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7589200

    5-Fluoro-4N-phenyl-4-pyrimidineamine compounds

    Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7585883

    Substituted pyridines and their uses

    Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7582648

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7576053

    Methods and compositions for treating degenerative bone disorders

    Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7569580

    Heterotricyclic compounds for use as HCV inhibitors

    Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7566732

    Rhodanine compositions for use as antiviral agents

    Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7563892

    Prodrugs of 2,4 pyrimidinediamine compounds and their uses

    Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7563585

    Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)

    Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7560466

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7557207

    Spiro 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7557210

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7550460

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7538108

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7521192

    EDG: modulators of lymphocyte activation and migration

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7517886

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7514434

    Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7511137

    Stereoisomers and stereoisomeric mixtures of 1-(2,4-pyrimidinediamino)-2-cyclopentanecarboxamide synthetic intermediates

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7498435

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7498353

    Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses

    Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7491732

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7488805

    Apoptosis proteins

    Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7485724

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7482351

    4-pyrimidineamine compounds and their uses as anti-proliferative agents

    Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7452879

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7449458

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7435814

    2,4-Pyrimidinediamine compounds and their uses

    Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7432047

    Method for selective inactivation of viral replication

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7423118

    IAPS associated cell cycle proteins, compositions and methods of use

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does RIGEL PHARMACEUTICALS have?

373 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do RIGEL PHARMACEUTICALS patents expire?

18 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.